This educational resource has been developed for healthcare professionals in Europe who are involved in the care of patients with asthma.
Disease Awareness - This section provides background information regarding the impact of symptomatic asthma and potential management strategies.
RCGP-accredited CME - Within the continuing medical education (CME) activity, you can learn about physician perspectives on managing symptomatic asthma in practice. Richard Russell and Thys van der Molen discuss in four sessions:
- What is asthma control: Who, why and how many?
- Improving asthma control in the community
- Current standard asthma treatment
- Pros and cons of additional add-on treatment.
One hour towards your CPD will be rewarded upon successful completion of the evaluation questionnaire
SPIRIVA® Respimat® is approved for use in asthma in the European Union, Japan and many other countries. It is currently being reviewed by other regulatory authorities such as the Food & Drug Administration in the United States. The indication varies by country and the educational resource may contain information about medications for which indications may not be approved in your country.